PDF herunterladen
Pharmacopsychiatry 2019; 52(06): 261-279
DOI: 10.1055/a-0942-1875
Review
© Georg Thieme Verlag KG Stuttgart · New York

The Role of Dietary Supplements in Depression and Anxiety – A Narrative Review

Knut Hoffmann
1   LWL University Hospital for Psychiatry, Psychotherapy and Preventive Medicine, Bochum, Germany
2   LWL Institute for Mental Health, Bochum, Germany
,
Barbara Emons
2   LWL Institute for Mental Health, Bochum, Germany
,
Stefan Brunnhuber
3   Diaconic Clinics Zschadrass, Colditz, Germany
,
Sedya Karaca
2   LWL Institute for Mental Health, Bochum, Germany
,
Georg Juckel
1   LWL University Hospital for Psychiatry, Psychotherapy and Preventive Medicine, Bochum, Germany
2   LWL Institute for Mental Health, Bochum, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 07. November 2018
revised 17. Mai 2019

accepted 20. Mai 2019

Publikationsdatum:
08. Juli 2019 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Introduction Dietary supplements are very widely used in the general population and there is a growing market for them, which is against the recommendations of the German Society for Nutrition. There is some evidence that dietary supplements are useful additions in the treatment of psychiatric disorders. This review is an overview of available practical knowledge regarding the use of supplements in psychiatric treatment. In particular, the review focused on the diagnosis of depression and anxiety in terms of supplement treatment.

Methods This is a narrative review of the evidence regarding supplements for treating anxiety and depression. We searched PubMed to 2018. Two reviewers screened the citations and abstracted the data. Phytopharmaceutical attends and animal-based data were excluded.

Results There are strong indications regarding the impact of supplements on the selected psychiatric disorders, but at this time, there only a few randomized clinical studies available, so evidence for these findings is quite low. However, it must be noted that there are strong hints for a relationship between vitamin D level and depression. Furthermore, various supplements have got potentially an influence on the characteristics of depression.

Discussion This review summarizes the current knowledge about supplements when used for some psychiatric conditions, but the data does not provide compelling evidence in any direction. There are only indications that there is an influence of supplements on psychiatric diseases. In support of this, there is further need for high-quality studies in this field. Reviews on other diagnoses, such as schizophrenia and dementia, will be part of further work.

Key words

supplements - depression - anxiety
 

  • References

  • 1 Deutsche Gesellschaft für Ernährung . Press information: Bunte Pillen für’s gute Gewissen – Was bringen Nahrungsergänzungsmittel?. Bonn: 2012. Accessed at www.dge.de/uplaods/media/DGE-Pressemeldungen-aktuell-09-2012-Brauchen-wir-NEM-JS.pdf Last accessed: July 10, 2018
    Google Scholar
  • 2 Nahrungsergänzungsmittel sind Verkaufsrenner. Dtsch Arztebl 2018 Accessed at www.aerzteblatt.de/treffer?mode=s&wo=17&typ=1&nid=95718&s=nahrungserg%E4nzungsmittel&s=sind&s=verkaufsrenner Last accessed: November 7, 2018
    PubMed
  • 3 Nahrungsergänzungsmitte: Deutsche setzen vor allem auf Magnesium. Dtsch Arztebl 2017 Accessed at www.aerzteblatt.de/treffer?mode=s&wo=17&typ=1&nid=73518&s=allem&s=auf&s=deutsche&s=magnesium&s=setzten&s=vor Last accessed: November 7, 2018
    PubMed
  • 4 Haller C, Kearney T, Bent S. et al. Dietary supplement adverse events: Report of one-year poison center surveillance project. J Med Tox 2008; 4: 84-92
    PubMedGoogle Scholar
  • 5 Rao N, Spiller HA, Hodges NL. An increase in dietary supplement exposure reported to US poison control centers. J Med Tox 2017; 13: 227-237
    PubMedGoogle Scholar
  • 6 Bjelakovic G, Dimitrinka N, Gluud LL. et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012; 3: CD007176
    PubMedGoogle Scholar
  • 7 Belzeaux R, Boyer L, Ibrahim EC. et al. Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia. Psychiatry Res 2015; 229: 613-616
    CrossrefPubMedGoogle Scholar
  • 8 Chu F, Ohinmaa A, Klarenbach S. et al. Serum 25-hydroxyvitamin D concentrations and indicators of mental health: An analysis of the Canadian Health Measures Survey. Nutrients 2017; 9: E1116
    CrossrefPubMedGoogle Scholar
  • 9 Collin C, Assmann KE, Deschasaux M. et al. Plasma vitamin D status and recurrent depressive symptoms in the French SU.VI.MAX cohort. European J Nutr 2017; 56: 2289-2298
    PubMedGoogle Scholar
  • 10 Mizoue T, Kochi T, Akter S. et al. Low serum 25-hydroxyvitamin D concentrations are associated with increased likelihood of having depressive symptoms among Japanese workers. J Nutr 2015; 145: 541-546
    CrossrefPubMedGoogle Scholar
  • 11 von Känel R, Fardad N, Steurer N. et al. Vitamin D deficiency and depressive symptomatology in psychiatric patients hospitalized with a current depressive episode: a factor analytic study. PLoS One 2015; 10: 1-15
    PubMedGoogle Scholar
  • 12 Jovanova O, Aarts N, Noordam R. et al. Vitamin D serum levels are cross-sectionally but not prospectively associated with late-life depression. Acta Psychiatr Scand 2017; 135: 185-194
    CrossrefPubMedGoogle Scholar
  • 13 Jääskeläinen T, Knekt P, Suvisaari J. et al. Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression. Br J Nutr 2015; 113: 1418-1426
    CrossrefPubMedGoogle Scholar
  • 14 Shin YC, Jung CH, Kim HJ. et al. The associations among vitamin D deficiency, C-reactive protein, and depressive symptoms. J Psychosom Res 2016; 90: 98-104
    CrossrefPubMedGoogle Scholar
  • 15 Thomas J, Al-Anouti F. Sun exposure and behavioral activation for hypovitaminosis D and depression: a controlled pilot study. Community Ment Health J 2018; 54: 860-865
    CrossrefPubMedGoogle Scholar
  • 16 Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord 2017; 208: 56-61
    CrossrefPubMedGoogle Scholar
  • 17 von Känel R, Fardad N, Steurer N. et al. Vitamin D deficiency and depressive symptomatology in psychiatric patients hospitalized with a current depressive episode: a factor analytic study. PLoS One 2015; 10: 1-15
    PubMedGoogle Scholar
  • 18 Belzeaux R, Annweiler C, Bertrand JA. et al. Association between hypovitaminosis D and cognitive inhibition impairment during major depression episode. J Affect Dis 2018; 225: 302-305
    CrossrefPubMedGoogle Scholar
  • 19 Lee SH, Suh E, Park KC. et al. Association of serum 25-hydroxyvitamin D and serum total cholesterol with depressive symptoms in Korean adults: the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V, 2010–2012). Public Health Nutrition 2017; 20: 1836-1843
    CrossrefPubMedGoogle Scholar
  • 20 Brouwer-Brolsma EM, Dhonukshe-Rutten RAM, van Wijngaarden JP. et al. Low vitamin D status is associated with more depressive symptoms in Dutch older adults. Eur J Nutr 2016; 55: 1525-1534
    CrossrefPubMedGoogle Scholar
  • 21 Accortt EE, Dunkel Schetter C, Peters RM. et al. Lower prenatal vitamin D status and postpartum depressive symptomatology in African American women: Preliminary evidence for moderation by inflammatory cytokines. Arch Womens Ment Health 2016; 19: 373-383
    CrossrefPubMedGoogle Scholar
  • 22 Johansson P, Alehagen U, van der Wal MH. et al. Vitamin D levels and depressive symptoms in patients with chronic heart failure. Int J Cardiol 2016; 207: 185-189
    CrossrefPubMedGoogle Scholar
  • 23 Kim SH, Seok H, Kim DS. Relationship between serum vitamin D levels and symptoms of depression in stroke patients. Ann Rehabil Med 2016; 40: 120-125
    CrossrefPubMedGoogle Scholar
  • 24 Rabenberg M, Harisch C, Rieckmann N. et al. Association between vitamin D and depressive symptoms varies by season: results from the German Health Interview and Examination Survey for Adults (DEGS1). J Affect Disord 2016; 204: 92-98
    CrossrefPubMedGoogle Scholar
  • 25 Kerr DC, Zava DT, Piper WT. et al. Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res 2015; 227: 46-51
    CrossrefPubMedGoogle Scholar
  • 26 Elstgeest LE, de Koning EJ, Brouwer IA. et al. Change in serum 25-hydroxyvitamin D and parallel change in depressive symptoms in Dutch older adults. Eur J Endocrinol 2018; 179: 239-249
    CrossrefPubMedGoogle Scholar
  • 27 Can MS, Baykan H, Erensoy N. et al. Vitamin d levels and vitamin D receptor gene polymorphism in major depression. Psychiatrica Danubia 2017; 29: 179-185
    PubMedGoogle Scholar
  • 28 Almeida OP, Hankey GJ, Yeap BB. et al. Vitamin D concentration and its association with past, current and future depression in older men: the Health in Men Study. Maturitas 2015; 81: 36-41
    CrossrefPubMedGoogle Scholar
  • 29 Callegari ET, Reavley N, Gorelik A. et al. Serum 25-hydroxyvitamin D and mental health in young Australian women: results from the Safe-D study. J Affect Disord 2017; 224: 48-55
    CrossrefPubMedGoogle Scholar
  • 30 van den Berg KS, Marijnissen RM, van den Brink RH. et al. Vitamin D deficiency, depression course and mortality: longitudinal results from the Netherlands Study on Depression in Older Persons (NESDO). J Psychosom Res 2016; 83: 50-56
    CrossrefPubMedGoogle Scholar
  • 31 Dana-Alamdari L, Kheirouri S, Noorazar SG. Serum 25-hydroxyvitamin D in patients with major depressive disorder. Iran J Public Health 2015; 44: 690-697
    PubMedGoogle Scholar
  • 32 Liu JJ, Galfalvy HC, Cooper TB. et al. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders. J Clin Psychiatry 2013; 74: 732-738
    CrossrefPubMedGoogle Scholar
  • 33 Otoki Y, Hennebelle M, Levitt AJ. et al. Plasma phosphatidylethanolamine and triacylglycerol fatty acid concentrations are altered in major depressive disorder patients with seasonal pattern. Lipids 2017; 52: 559-571
    CrossrefPubMedGoogle Scholar
  • 34 Rakofsky JJ, Dunlop BW. Review of nutritional supplements for the treatment of bipolar depression. Depress Anxiety 2014; 31: 379-390
    CrossrefPubMedGoogle Scholar
  • 35 Hashimoto K, Ishima T, Sato Y. et al. Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study. Sci Rep 2017; 3485: 1-7
    PubMedGoogle Scholar
  • 36 Payne ME, Steck SE, George RR. et al. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression. J Acad Nutr Diet 2012; 112: 2022-2027
    CrossrefPubMedGoogle Scholar
  • 37 Mulcahy K, Trigoboff E, Opler L. et al. Physician prescribing practices of vitamin D in a psychiatric hospital. Innov Clin Neurosci 2016; 13: 21-27
    PubMedGoogle Scholar
  • 38 Stokes CS, Grünhage F, Baus C. et al. Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clin Nutr 2016; 35: 950-957
    CrossrefPubMedGoogle Scholar
  • 39 Penckofer S, Byrn M, Adams W. et al. Vitamin D supplementation improves mood in women with type 2 diabetes. J Diabetes Res 2017; 2017: 8232863
    PubMedGoogle Scholar
  • 40 Gowda U, Mutowo MP, Smith BJ. et al. Vitamin D supplementation to reduce depression in adults: Meta-analysis of randomized controlled trials. Nutrition 2015; 31: 421-429
    CrossrefPubMedGoogle Scholar
  • 41 Mousa A, Naderpoor N, de Courten MP. et al. Vitamin D and symptoms of depression in overweight or obese adults: a cross-sectional study and randomized placebo-controlled trial. J Steroid Biochem Mol Biol 2018; 177: 200-208
    CrossrefPubMedGoogle Scholar
  • 42 Marsh WK, Penny JL, Rothschild AJ. Vitamin D supplementation in bipolar depression: a double blind placebo controlled trial. J Psychiatr Res 2017; 95: 48-53
    CrossrefPubMedGoogle Scholar
  • 43 Kjærgaard M, Waterloo K, Wang CE. et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 2012; 201: 360-368
    CrossrefPubMedGoogle Scholar
  • 44 Sepehrmanesh Z, Kolahdooz F, Abedi F. et al. Vitamin D supplementation affects the Beck Depression Inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. J Nutr 2016; 146: 243-248
    CrossrefPubMedGoogle Scholar
  • 45 Rolf L, Muris AH, Bol Y. et al. Vitamin D3 supplementation in multiple sclerosis: Symptoms and biomarkers of depression. J Neurol Sci 2017; 378: 30-35
    CrossrefPubMedGoogle Scholar
  • 46 Yalamanchili V, Gallagher JC. Dose ranging effects of vitamin D3 on the geriatric depression score: a clinical trial. J Steroid Biochem Mol Biol 2018; 178: 60-64
    CrossrefPubMedGoogle Scholar
  • 47 Frandsen TB, Pareek M, Hansen JP. et al. Vitamin D supplementation for treatment of seasonal affective symptoms in healthcare professionals: A double-blind randomised placebo-controlled trial. BMC Res Notes 2014; 528: 1-8
    PubMedGoogle Scholar
  • 48 Stefanowski B, Antosik-Wójcińska AZ, Święcicki Ł. Wpływ niedoboru witaminy D3 na poziom nasilenia objawów depresyjnych. Przegląd aktualnych badań. Psychiatr Pol 2017; 51: 437-454
    CrossrefPubMedGoogle Scholar
  • 49 Smith DJ, Sarris J, Dowling N. et al. Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: an open-label pilot trial. Nutr Neurosci 2018; 21: 224-228
    CrossrefPubMedGoogle Scholar
  • 50 Kiecolt-Glaser JK, Belury MA, Andridge R. et al. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 2011; 25: 1725-1734
    CrossrefPubMedGoogle Scholar
  • 51 Kiecolt-Glaser JK, Belury MA, Porter K. et al. Depressive symptoms, n-6:n-3 fatty acids, and inflammation in older adults. Psychosom Med 2007; 69: 217-224
    CrossrefPubMedGoogle Scholar
  • 52 Masoumi SZ, Kazemi F, Tavakolian S. et al. Effect of Citalopram in combination with omega-3 on depression in post-menopausal women: A triple blind randomized controlled trial. J Clin Diagn Res 2016; 10: 1-5
    CrossrefPubMedGoogle Scholar
  • 53 Khajehnasiri F, Akhondzadeh S, Mortazavi SB. et al. Are supplementation of omega-3 and ascorbic acid effective in reducing oxidative stress and depression among depressed shift workers?. Int J Vitam Nutr Res 2015; 85: 299-310
    CrossrefPubMedGoogle Scholar
  • 54 Khajehnasiri F, Mortazavi SB, Allameh A. et al. Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tomdgoyan Oil Refinery, Iran: A randomized double-blind placebo-controlled study. J Clin Biochem Nutr 2013; 53: 36-40
    CrossrefPubMedGoogle Scholar
  • 55 Messamore E, Almeida DM, Jandacek RJ. et al. Polyunsaturated fatty acids and recurrent mood disorders: phenomenology, mechanisms, and clinical application. Prog Lipid Res 2017; 66: 1-13
    CrossrefPubMedGoogle Scholar
  • 56 Mocking RJ, Harmsen I, Assies J. et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry 2016; 6: 1-6
    PubMedGoogle Scholar
  • 57 Sarris J. Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders. Austral Psychiatry 2017; 25: 369-372
    PubMedGoogle Scholar
  • 58 Du J, Zhu M, Bao H. et al. The role of nutrients in protecting mitochondrial function and neurotransmitter signaling: Implications for the treatment of depression, PTSD, and suicidal behaviours. Crit Rev Food Sci Nutr 2016; 56: 2560-2578
    CrossrefPubMedGoogle Scholar
  • 59 Trebatická J, Dukát A, Ďuračková Z. et al. Cardiovascular diseases, depression disorders and potential effects of omega-3 fatty acids. Physiol Res 2017; 66: 363-382
    PubMedGoogle Scholar
  • 60 Parletta N, Zarnowiecki D, Cho J. et al. A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: a randomized controlled trial (HELFIMED). Nutr Neurosci 2017; 22: 474-487
    PubMedGoogle Scholar
  • 61 Sahraian A, Ghanizadeh A, Kazemeini F. Vitamin C as an adjuvant for treating major depressive disorder and suicidal behaviour, a randomized placebo-controlled clinical trial. Trials 2015; 94: 1-8
    PubMedGoogle Scholar
  • 62 Payne ME, Steck SE, George RR. et al. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression. J Acad Nutr Diet 2012; 112: 2022-2027
    CrossrefPubMedGoogle Scholar
  • 63 Nguyen TT, Tsujiguchi H, Kambayashi Y. et al. Relationship between vitamin intake and depressive symptoms in elderly Japanese individuals: differences with gender and body mass index. Nutrients 2017; 1319: 1-16
    PubMedGoogle Scholar
  • 64 Singh A, Trumpff C, Genkinger J. et al. Micronutrient dietary intake in Latina pregnant adolescents and its association with level of depression, stress, and social support. Nutrients 2017; 1212: 1-16
    PubMedGoogle Scholar
  • 65 Sarris J, Murphy J, Mischoulon D. et al. Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatry 2016; 173: 575-587
    CrossrefPubMedGoogle Scholar
  • 66 Wu C, Ren W, Cheng J. et al. Association between serum levels of vitamin D and the risk of post-stroke anxiety. Medicine (Baltimore) 2016; 95: 1-5
    PubMedGoogle Scholar
  • 67 de Koning EJ, Verweij L, Lips P. et al. The relationship between serum 25(OH)D levels and anxiety symptoms in older persons: Results from the Longitudinal Aging Study Amsterdam. J Psychosom Res 2017; 97: 90-95
    CrossrefPubMedGoogle Scholar
  • 68 Green P, Hermesh H, Monselise A. et al. Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol 2006; 16: 107-113
    CrossrefPubMedGoogle Scholar
  • 69 de Oliveira IJ, de Souza VV, Motta V. et al. Effects of oral vitamin C supplementation on anxiety in students: a double-blind, randomized, placebo-controlled trial. Pak J Biol Sci 2015; 18: 11-18
    CrossrefPubMedGoogle Scholar
  • 70 Mazloom Z, Ekramzadeh M, Hejazi N. Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type-2 diabetic patients: a randomized, single-blind, placebo-controlled trial. Pak J Biol Sci 2013; 1-4
    PubMedGoogle Scholar
  • 71 Gautam M, Agrawal M, Gautam M. et al. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry 2012; 54: 244-247
    CrossrefPubMedGoogle Scholar